A Study of the Systemic Metabolic Contribution from the Contents of Continuous Renal Replacement Therapy
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 13-009155
NCT ID: NCT02998346
Sponsor Protocol Number: 13-009155
About this study
The purpose of this study is to measure the number of calories delivered from fluids used in continuous renal replacement therapy. This could help better estimate how much nutrition patients in the Critical Care Unit should get every day from other sources like tube feeding or nutrition through a person's veins.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Age greater than or equal to 18 years
- In an intensive care unit and anticipated to receive greater than or equal to 24 hours of continuous venovenous blood filtration
- Receiving regional citrate anticoagulation with ACD-A solution
Exclusion Criteria
- Vulnerable adults
- Pregnant
- BMI > 40
- On extracorporeal membrane oxygenation therapy
- Reversal of port connections on the dialysis catheter and dialysis circuit lines
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Erin Nystrom, Pharm.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available